CELLULAR ANTI-GP120 CYTOLYTIC REACTIVITIES IN HIV-1 SEROPOSITIVE INDIVIDUALS

Kent J. Weinhold; Thomas J. Matthews; Paul M. Ahearne; Alphonse J. Langlois; H. Kim Lyerly; Douglas S. Tyler; Kimo C. Stine; David T. Durack; Dani P. Bolognesi

doi:10.1016/S0140-6736(88)91713-8

CELLULAR ANTI-GP120 CYTOLYTIC REACTIVITIES IN HIV-1 SEROPOSITIVE INDIVIDUALS

Kent J. Weinhold
, Thomas J. Matthews
, Paul M. Ahearne
, Alphonse J. Langlois
, H. Kim Lyerly
, Douglas S. Tyler
, Kimo C. Stine
, David T. Durack
, Dani P. Bolognesi

Research output: Contribution to journal › Article › peer-review

111 Scopus citations

Abstract

Forty-one patients seropositive for human immunodeficiency virus type 1 (HIV-1) were assessed for cell-mediated cytotoxicity (CMC) against autologous target cells bearing the major envelope glycoprotein of HIV-1, gp120. Effector lymphocytes from over 85% of seropositive patients showed CMC specific for gp120-coated targets, whereas seronegative individuals had no detectable CMC. As a group, symptomless individuals had the highest levels of CMC; patients with AIDS-related complex and AIDS showed progressively diminished reactivity. The gp120-specific CMC was mediated by a population of non-T-cell effectors phenotypically resembling NK/K cells. Cytolysis was not restricted by major histocompatibility complex determinants, as shown by killing of heterologous gp120-adsorbed targets and of HIV-1-infected cell-lines. Gp120-specific CMC was highly augmented in the presence of interleukin 2, so it may be possible to develop therapeutic strategies aimed at destruction of virus-producing cell reservoirs in infected individuals through stimulation of HIV-specific host CMC.

Original language	English (US)
Pages (from-to)	902-905
Number of pages	4
Journal	The Lancet
Volume	331
Issue number	8591
DOIs	https://doi.org/10.1016/S0140-6736(88)91713-8
State	Published - Apr 23 1988
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0140-6736(88)91713-8

Cite this

@article{c8012208d22743e7b49f646336c310b6,

title = "CELLULAR ANTI-GP120 CYTOLYTIC REACTIVITIES IN HIV-1 SEROPOSITIVE INDIVIDUALS",

abstract = "Forty-one patients seropositive for human immunodeficiency virus type 1 (HIV-1) were assessed for cell-mediated cytotoxicity (CMC) against autologous target cells bearing the major envelope glycoprotein of HIV-1, gp120. Effector lymphocytes from over 85\% of seropositive patients showed CMC specific for gp120-coated targets, whereas seronegative individuals had no detectable CMC. As a group, symptomless individuals had the highest levels of CMC; patients with AIDS-related complex and AIDS showed progressively diminished reactivity. The gp120-specific CMC was mediated by a population of non-T-cell effectors phenotypically resembling NK/K cells. Cytolysis was not restricted by major histocompatibility complex determinants, as shown by killing of heterologous gp120-adsorbed targets and of HIV-1-infected cell-lines. Gp120-specific CMC was highly augmented in the presence of interleukin 2, so it may be possible to develop therapeutic strategies aimed at destruction of virus-producing cell reservoirs in infected individuals through stimulation of HIV-specific host CMC.",

author = "Weinhold, \{Kent J.\} and Matthews, \{Thomas J.\} and Ahearne, \{Paul M.\} and Langlois, \{Alphonse J.\} and Lyerly, \{H. Kim\} and Tyler, \{Douglas S.\} and Stine, \{Kimo C.\} and Durack, \{David T.\} and Bolognesi, \{Dani P.\}",

year = "1988",

month = apr,

day = "23",

doi = "10.1016/S0140-6736(88)91713-8",

language = "English (US)",

volume = "331",

pages = "902--905",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "8591",

}

TY - JOUR

T1 - CELLULAR ANTI-GP120 CYTOLYTIC REACTIVITIES IN HIV-1 SEROPOSITIVE INDIVIDUALS

AU - Weinhold, Kent J.

AU - Matthews, Thomas J.

AU - Ahearne, Paul M.

AU - Langlois, Alphonse J.

AU - Lyerly, H. Kim

AU - Tyler, Douglas S.

AU - Stine, Kimo C.

AU - Durack, David T.

AU - Bolognesi, Dani P.

PY - 1988/4/23

Y1 - 1988/4/23

N2 - Forty-one patients seropositive for human immunodeficiency virus type 1 (HIV-1) were assessed for cell-mediated cytotoxicity (CMC) against autologous target cells bearing the major envelope glycoprotein of HIV-1, gp120. Effector lymphocytes from over 85% of seropositive patients showed CMC specific for gp120-coated targets, whereas seronegative individuals had no detectable CMC. As a group, symptomless individuals had the highest levels of CMC; patients with AIDS-related complex and AIDS showed progressively diminished reactivity. The gp120-specific CMC was mediated by a population of non-T-cell effectors phenotypically resembling NK/K cells. Cytolysis was not restricted by major histocompatibility complex determinants, as shown by killing of heterologous gp120-adsorbed targets and of HIV-1-infected cell-lines. Gp120-specific CMC was highly augmented in the presence of interleukin 2, so it may be possible to develop therapeutic strategies aimed at destruction of virus-producing cell reservoirs in infected individuals through stimulation of HIV-specific host CMC.

AB - Forty-one patients seropositive for human immunodeficiency virus type 1 (HIV-1) were assessed for cell-mediated cytotoxicity (CMC) against autologous target cells bearing the major envelope glycoprotein of HIV-1, gp120. Effector lymphocytes from over 85% of seropositive patients showed CMC specific for gp120-coated targets, whereas seronegative individuals had no detectable CMC. As a group, symptomless individuals had the highest levels of CMC; patients with AIDS-related complex and AIDS showed progressively diminished reactivity. The gp120-specific CMC was mediated by a population of non-T-cell effectors phenotypically resembling NK/K cells. Cytolysis was not restricted by major histocompatibility complex determinants, as shown by killing of heterologous gp120-adsorbed targets and of HIV-1-infected cell-lines. Gp120-specific CMC was highly augmented in the presence of interleukin 2, so it may be possible to develop therapeutic strategies aimed at destruction of virus-producing cell reservoirs in infected individuals through stimulation of HIV-specific host CMC.

UR - https://www.scopus.com/pages/publications/0023886334

UR - https://www.scopus.com/pages/publications/0023886334#tab=citedBy

U2 - 10.1016/S0140-6736(88)91713-8

DO - 10.1016/S0140-6736(88)91713-8

M3 - Article

C2 - 2895830

AN - SCOPUS:0023886334

SN - 0140-6736

VL - 331

SP - 902

EP - 905

JO - The Lancet

JF - The Lancet

IS - 8591

ER -

CELLULAR ANTI-GP120 CYTOLYTIC REACTIVITIES IN HIV-1 SEROPOSITIVE INDIVIDUALS

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this